Consumer

By Dave Muoio February 8, 2018
Following a soft launch last year, the chemoWave disease companion app has now been fully released for chemotherapy patients interested in better managing their care, symptoms, and side effects. The app, which is available for free download on iOS, was heavily influenced by Treatment Technologies & Insights, LLC cofounder Matt Lashey’s experiences during the time his partner was undergoing...
By Laura Lovett February 7, 2018
A new alcohol and drug recovery app that incentives users with its own cryptocurrency hit the market this week. Atlanta-based Hayver has just launched its new mobile app that uses behavioral modification and a support network to help people who are living with alcohol addiction.  “Its foundation is taken from physicians and pilot treatment programs and proven research that [shows] people who...
By Jonah Comstock February 7, 2018
Mirror, a New York City-based virtual fitness platform company, has raised $13 million in a new funding round led by Spark Capital. Lerer Hippeau, First Round Capital, Primary Venture Partners, BoxGroup, and Brainchild Holdings also contributed to the round.  Founded by New York City ballet dancer and fitness studio owner Brynn Putnam, the company will offer a hardware product that takes on the...
By Dave Muoio February 7, 2018
With influenza running rampant and several other infections waiting in the wings, some may be interested in knowing whether a specific disease is common in their community. With the recent release of the free Doctors Report Illness Tracker, the public has another resource where they can easily check how often doctors have reported a selection of 15 diseases within a specific US zip code. “...
By Laura Lovett February 1, 2018
Whether you're Tom Brady or Nick Foles, getting a good night's sleep is key for professional athletes. Just days before the Super Bowl, the National Football League announced that it is teaming up with Sleep Number for a multi-year partnership aimed at helping the players get better sleep.  “We are constantly assessing world-class technologies and partners and know this unprecedented partnership...
By Dave Muoio January 31, 2018
San Francisco- and Zurich-based Ava, which makes a bracelet capable of tracking women’s menstrual cycles, has announced an update that will better allow their device to track when, or even if, the wearer has ovulated, according to a statement from the company. Data collected by the Ava bracelet and companion app will be used to detect biphasic shifts among skin temperature, pulse rate, and other...
By Laura Lovett January 30, 2018
Consumers now have another option to turn to when looking for a  new doctor with the recent launch of mobile provider search tool Welloh. The free app is designed to help users navigate their healthcare options. It gives users information about hospitals, pharmacies, care centers, and facilities.  "The information that would enable consumers to make choices about healthcare services has never...
By Jonah Comstock January 25, 2018
When Fitbit acquired indie smartwatch maker Pebble at the end of 2016, it was clear from the beginning that it would be the end of the line for Pebble devices. In fact, Fitibit didn't even acquire Pebble's hardware assets. A year later, Fitbit seems determined to let Pebble's fiercely loyal userbase down easy — and to convert as many of them as possible into users of the company's fledgling...
By Jonah Comstock January 24, 2018
New Zealand-based smart inhaler company Adherium, which up until now has distributed its products via pharma sales channels in Europe and Australia, plans to expand into the United States in the first half of 2018 with a direct-to-consumer (and direct-to-payer) strategy. “We’ve had a great relationship over the last couple of years with AstraZeneca, we’ve launched in a couple dozen countries now...
By Laura Lovett January 22, 2018
Nokia has announced that it will disable the pulse wave velocity measurement feature on its Withings’ Body Cardio scale as of January 24. The company said it is now learning the technology may require a different level of regulatory approval. However, no specific regulation is cited and the company said the FDA did not recommend or request the removal.  “There was not a specific regulatory issue...

Editor's Pick